Stay updated on Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe study record history shows that revision v3.5.2 was added and revision v3.5.0 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision entry (v3.4.3) was added and the v3.4.2 entry removed from the study record history.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision: v3.4.2 has been added to the record history. The government funding lapse notice and the previous Revision: v3.4.1 have been removed.SummaryDifference0.7%

- Check77 days agoChange DetectedA banner notice about a lapse in government funding was added to the page, and the history now shows a new site revision (v3.4.1) replacing the previous version (v3.4.0).SummaryDifference0.7%

- Check84 days agoChange DetectedAdded UI elements such as showing the glossary, green and red highlights, and the revision label v3.4.0; removed the older No FEAR Act data label and the v3.3.4 revision reference.SummaryDifference0.9%

Stay in the know with updates to Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zevor-cel in Relapsed/Refractory Multiple Myeloma Clinical Trial page.